TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 77 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,641 | +19.3% | 11,291 | +21.3% | 0.00% | – |
| Q2 2023 | $168,159 | +16.6% | 9,306 | -18.9% | 0.00% | – |
| Q1 2023 | $144,228 | +31.4% | 11,474 | +53.2% | 0.00% | – |
| Q4 2022 | $109,789 | -12.9% | 7,489 | +1.7% | 0.00% | – |
| Q3 2022 | $126,000 | +0.8% | 7,367 | -14.1% | 0.00% | – |
| Q2 2022 | $125,000 | +58.2% | 8,572 | +81.4% | 0.00% | – |
| Q1 2022 | $79,000 | -38.3% | 4,726 | -16.9% | 0.00% | – |
| Q4 2021 | $128,000 | +10.3% | 5,687 | +5.0% | 0.00% | – |
| Q3 2021 | $116,000 | -28.0% | 5,417 | -2.8% | 0.00% | – |
| Q2 2021 | $161,000 | +26.8% | 5,574 | +41.6% | 0.00% | – |
| Q1 2021 | $127,000 | -28.7% | 3,936 | -8.8% | 0.00% | – |
| Q4 2020 | $178,000 | – | 4,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,034,158 | $25,569,366 | 3.81% |
| Vivo Capital, LLC | 2,262,200 | $28,435,854 | 1.97% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $22,469,214 | 1.63% |
| Cormorant Asset Management, LP | 1,421,422 | $17,867 | 1.18% |
| Sands Capital Ventures, LLC | 260,000 | $3,268,200 | 0.81% |
| RTW INVESTMENTS, LP | 2,548,125 | $32,029,931 | 0.67% |
| Perceptive Advisors | 1,296,416 | $16,295,949 | 0.48% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,156,032 | $14,531,322 | 0.32% |
| Ghost Tree Capital, LLC | 80,000 | $1,006,000 | 0.30% |
| TimesSquare Capital Management, LLC | 1,192,660 | $14,992 | 0.22% |